Recent serious hospital cross-infection in
Bristol was caused by a strain of Klebsiella aerogenes which was phenotypically resistant to a wide range of penicillins and cephalosporins and to tetracycline, streptomycin, kanamycin, gentamicin, tobramycin, sulfonamides, nitrofurantoin, trimethoprim, and nalidixic acid (D. C. E. Speller, unpublished data). Examination of the basis of the resistance to ,Blactam antibiotics showed that the strains produced a (8- on agar containing ampicillin (500 Ag/ml) and rifampin (100 ug/ml). The penicillin resistance of the exconjugants obtained in this way was primarily due to 8-lactamase production. The transfer of penicillin resistance to the recipient E. coli by conjugation was accompanied by the appearance in strain UB1139 of one plasmid of molecular weight 64 x 106. This plasmid has been designated pUB5451. The original Klebsiella strain, on the other hand, carried three plasmids, one of which also had a molecular weight about 64 x 106, the other two being smaller.
To determine the type of /8-lactamase synthesized by E. coli UB1139 after receiving the penicillin resistance character from the Klebsiella strain, several E. coli lines (Table 1) were grown to a culture density of about 2 x 109 bacteria/ml in nutrient broth. The bacteria were then collected by centrifugation and resuspended in about one-fifth of their original volume of 0.1 M Na2HPQ4/KH2PO4 buffer, pH 7.0. This suspension was then disrupted in an ultrasonic disintegrator as described by Jack and Richmond (4); the cell debris was removed by further centrifugation, and the supernatant fluid was used for enzyme studies.
The substrate profile of the enzyme was determined against a range of 8-lactam antibiotics as described previously (7) . Crude enzyme preparations of three other j8-lactamases that are (also) mediated by bacterial plasmids (type lIla, Va, and Vb enzymes; see references 7, 8) were also tested for comparison. The results are shown in Table 1 . They have been calculated so that the rate of hydrolysis ofbenzyl penicillin is recorded as 100 in each case (7) . The results obtained with the Klebsiella enzyme were different from those obtained with others in certain respects. Thus, type IIIa enzyme was considerably more active than the Klebsiella enzyme against cephaloridine and cephalexin, whereas the type Va and Vb enzymes hydrolyzed cloxacillin, a penicillin barely affected by the new ,3-lactamase. As with the majority of 8-lactamases from gram-negative species, cefuroxime and cefoxitin were stable to the new enzyme, having rates of hydrolysis less than 2% of those found with benzyl penicillin (Table   1) .
Among the ,8-lactamases from gram-negative species, cefuroxime, cloxacillin, and clavulanic acid are commonly inhibitors of cephaloridine hydrolysis. Crude preparations of the new enzyme were therefore examined to see whether these /8-lactam compounds were inhibitors. In all cases they were ( Table 2) .
Isoelectric focusing of /-lactamases in poly- acrylamide gels has proved an effective way of resolving molecular differences in these molecules (5). The novel f-lactamase was therefore subjected to isoelectric focusing under standard conditions (5) , and the migration of crude preparations of type IIIa, Va, and Vb enzymes was included for comparison. The isoelectric point (pI) values obtained are shown in Table 3 . The penicillin-susceptible E. coli UB1139, which was used as the recipient in the initial transfer experiment from the Klebsiella strain, itself expresses small amounts of type Ib (8-lactamase, an enzyme commonly found in strains derived from E. coli K-12 (1). The pI of this enzyme is 8. strain showed that it was indistinguishable from that expressed in E. coli after mating. On the basis of the evidence summarized here, therefore, we conclude that a hitherto unrecognized (8-lactamase was responsible for the penicillin and cephalosporin resistance of the K. aerogenes strains studied here. It is, as yet, uncertain whether this enzyme is widespread among clinical strains of gram-negative bacteria or whether it is still confined to a relatively small clone ofK. aerogenes.
We would like to thank Glaxo Research Limited for a gift of clavulanic acid. One of us (V.P.) is supported by a Fellowship from the British Council.
LITERATURE CITED
